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STEM CELLS IN BONE REGENERATION  
IN DENTISTRY 
 
GIBRAN MANGUI 
 
 
ABSTRACT 
 
In the recent years, stem cell research has leaped to the field of dentistry 
in the hopes of finding a method to ethically and efficiently develop better ways 
for bone regeneration. Stem cell research is the most valuable study in the dental 
field, and various types of adult stem cells have been found in the oral cavity, 
including stem cells from apical papilla, stem cells from human deciduous teeth, 
dental follicle stem cells, and dental pulp stem cells. These dental stem cells 
have the potential and ability to form specialized neuronal cells, which can be 
used for therapies. In addition to the benefit in the oral cavity, stem cells can 
serve as the front for therapeutic applications in the spinal cord, the brain, and 
other nerve regeneration treatments. This thesis will summarize existing studies 
involving stem cells and bone regeneration treatments and upcoming initial 
clinical trials using oral cavity stem cells for craniofacial bone regeneration.  
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INTRODUCTION 
 
 Stem cells have been researched heavily in recent past.  However, 
studies as early as 1924 by Alexander Maksimov identified a precursor 
mesenchymal cell within the bone marrow which would develop into more than 
one cell type. Stem cell biology is seen as one solution to the regeneration of 
neurons and as a potential tool for the replacement of damaged organs; 
unfortunately research still continues as there are many challenges associated 
with efficiently obtaining stem cells and the direction for which to go with modern 
science. The oral cavity has been shown to be a site where stem cells are found 
and thus suggest a very promising therapeutic approach to several structural 
defects, including bone generation and growth (DiPietro, 2014). A stem cell 
possesses both potency and self-renewal. Several review articles have been 
published, along with primary articles describing studies in order to identify a 
platform to regenerate tissue and stem cells, specifically utilization for bone 
regeneration (Avinash et al, 2017; Strong et al, 2017; Heng et al, 2017).  
 The capacity of bone regeneration has several limitations on 
reconstructive techniques and tissue engineering; however, its importance has a 
varying range as the skeleton itself acts as a regulator for homeostasis and the 
oral and craniofacial region have roles in several critical functions such as 
speech, mastication, and the effects of these on self-esteem and general overall 
health. There are many cases in which skeletal bone regeneration does not 
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occur spontaneously, such as a skeletal injury beyond a certain size (Strong et 
al, 2017). Additionally, there are many deformities, traumas, and levels of 
degenerative diseases in which large amounts of bone are necessary for 
reconstruction. Even though the “gold standard” for reconstruction is through 
bone grafts, alloplastic materials still remain part of the clinical process 
(Walmsley et al, 2016). The risk of infection through alloplastic materials 
combined with an insufficient amount of bone grafts has fueled the search for 
other approaches to repair large bone defects. 
  
Bone Development and Wound Repair 
 Bone is composed of a mineral component and an organic matrix in a 
mineralized dense connective tissue. The organic matrix consists of mainly Type 
I collagen with Type III collagen. Between individual collagen molecules, 
hydroxyapatite is found and provides rigidity to bone. Mesenchymal stem cells, 
which can self-renew and differentiate into different cell lines, can play a role in 
bone development and fracture healing/bone remodeling (Walmsley et al, 2016). 
The development of the skeleton is aided by mesenchymal groups whose stem 
cells mature into cartilage and later into hypertrophic cartilage, which is then 
replaced by bone and marrow (Walmsley et al, 2016). During osteogenesis, the 
majority of osteoprogenitor cells produce extracellular matrix although there is a 
high cellular content present. There are a limited number of cells that can be 
made in already synthesized bone tissue. The bone remodeling process consists 
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of degradation of the extracellular matrix by the multinucleated osteoclast cells 
(Figure 1). Many different types of cells contribute to the generation of the 
complex 3 dimensional (D) bone tissue at the early stage of its formation, 
however once it reaches its mature state, only a few cells are abundant in the 
extracellular matrix (Gomez-Barrena et al, 2011).  
 
 
 
 
Figure 1: Bone Remodeling. Figure represents the growth process where 
mature bone tissue is taken out of the skeleton while new bone tissue is formed 
through osteocyte to an osteoclast then to an osteoblast.  Figure taken from 
Encyclopedia Britannica, n.d. 
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 After injury, the wound healing process begins and can be divided into 
several phases (Figure 2) (Shield Health, n.d.). The first phase, hemostasis, 
starts immediately after injury and hematoma formation occurs. During the 
second phase, inflammatory cells enter the clot and prevent infection and also 
initiate further cellular signaling cascades. During the proliferative phase or the 
third phase of wound healing, keratinocytes function to close the wound while the 
wound size decreases by myofibroblast contraction. The extracellular matrix is 
allowed to remodel itself and form a scar with a strength of 80% comparable to 
that of its original, unharmed skin. The clot, or hematoma, that is formed during 
the first phase, provides a temporary matrix in which cells can through migrate 
through during this wound healing process. The hematoma releases cytokines, 
and other growth factors such as TGF-beta, insulin-like growth factor, and 
epidermal growth factor.   
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Figure 2:  The Four Stages of Wound Healing.  Wound healing entails four 
stages, hemostasis, inflammatory, proliferative and ultimately remodeling. Figure 
taken from Shield Health, n.d. 
  
6 
 
 
During the fracture healing process, hematoma formation occurs. After the 
hematoma forms, inflammatory cells enter the hematoma and prevent infection, 
releasing cytokines, growth factors, and other platelets which release TGF-beta 
(transforming growth factor beta ) and PDGF (platelet derived growth factor). 
PDGF plays a significant role in blood vessel formation. Through these steps, it is 
that mesenchymal stem cell differentiation is able to proceed (Shakoori et al, 
2017).   
 Bone tissue, as described, is capable of self-repair but in some instances, 
the defect is too large. Bone grafting is the gold standard for bone repair today, 
although the costs of this are considerable due to the additional surgical 
procedures required to harvest the bone. Furthermore, this process is hindered 
by the limited amount of donor material available. To resolve these issues, both 
allograft and xenograft based strategies have been proposed but it has been 
demonstrated that these run with high risks of rejection. Bone tissue engineering 
is an alternative strategy that has been explored. Much of this still has yet to be 
studied because of financial limitations and because of low efficiency of 
differentiation, intrapatient variability, and the risk of ectopic bone growth (Fisher 
et al, 2016). Some studies that have clinical applications with bone tissue 
engineering are mentioned in the published studies section of this thesis. 
Connective tissue progenitors (CTP’s) are used to describe the heterogeneous 
system of stem cells and progenitor cells that are present in native tissues, which 
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can proliferate and generate one or more connective tissues like bone, cartilage, 
fat, fibrous tissue, muscle, and blood. Colnot et al, 2012, has demonstrated the 
periosteum and endosteum and rich sources of osteochondral progenitor cells 
during fracture healing. Grafting experiments revealed that the transplanted 
periosteum generates both osteoblasts and chondrocytes during fracture repair, 
which transplanted endosteum generates primary osteoblasts. Circulating CTP’s 
that are mobilized into circulation following an injury may also contribute to 
fracture healing. However, this same study showed that circulating cells only 
contribute a small number of cells in the fracture callus and thus therapeutic 
therapies are needed to make a difference in the healing process (Colnot et al, 
2012). The most common source of CTPs is bone marrow from the iliac crest. 
Hermigou et al (2016) demonstrated successful treatment of diaphyseal 
nonunions with marrow-derived cells can be achieved as long as at least 50,000 
CTPs are implanted at the site of the nonunion. Because native tissues have 
such a small number of CTPs, mesenchymal stem cells (MSCs) are very useful 
because of their different roles in bone repair. MSCs can differentiate into 
osteoblasts, trigger the division and differentiation of native CTPs, modulate cells 
of the immune system, and secrete trophic molecules that inhibit apoptosis and 
fibrosis and/or promote angiogenesis (Marcucio et al, 2015). While MSCs are the 
most frequently studied and characterized, several preclinical studies have also 
not demonstrated success, although clinical data is fairly limited. Other stem cell 
populations, like endothelial progenitor cells, can be more useful for other certain 
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therapeutic applications. Endothelial progenitor cells have been shown to 
contribute to bone and vasculature in vitro. One recent study suggested that 
therapy with endothelial progenitor cells was superior to MSC therapy in a bone 
defect model in the rat (Nauth et al, 2010). There are, however, still a number of 
barriers before stem cells can be fully clinically used in fracture healing and bone 
remodeling. Protocols for the expansion and differentiation of MSCs are 
established and repeatable; however, they differ depending on the in vivo niche 
from which the founding CTPs were isolated. Additionally, the concentration and 
prevalence of CTPs decreases in frequency and function with age. This should 
be able to be overcome with in vitro expansion of CTPs but very few clinical 
studies have been done in order to fully confirm this solution. The contribution of 
MSCs to new tissue formation is also unclear, because long-term engraftment of 
transplanted MSCs has not been readily observed. The effect of transplanted 
MSCs has largely focused on factors that MSCs may secrete although clinical 
trials have shown that MSCs reduce graft versus host disease (Prockop, 2013). 
Another improvement to make is the injection technique used in studies. 
Therapeutically, stem cells are often injected systemically or locally, but 
engraftment of cells delivered by this mechanism is generally low. Reducing 
strain by injecting cells at a slower rate, using a larger needle, or employing a 
viscous solution when injected may help improve cell viability (Marcucio et al, 
2015).  
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Stem Cells 
 
 There are three categories of stem cells: adult stem cells, embryonic stem 
cells, and induced pluripotent stem cells (Figures 3 & 4) (Slide Share, n.d and 
Roberts, 2015).  
 
 
 
Figure 3: Types of Stem Cells. Summary of embryonic, adult, and induced 
pluripotent stem cells and their major characteristics (Figure taken from 
SlideShare, n.d.) 
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Figure 4:  Three different categories of stem cells.  Both human embryonic 
stem (hES) cells and induced pluripotent stem (iPS) cells are pluripotent: they 
can become any type of cell in the body. While hES cells are isolated from an 
embryo, iPS cells can be made from adult cells. Figure taken from Roberts 
(2015).  
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Adult stem cells are found in the bone marrow and periosteum, including 
the orofacial tissues like teeth, dental pulp, and supporting structures. Those 
from orofacial tissues can then be classified into two categories: dental stem cells 
and nondental oral stem cells. Types of dental stem cells include dental pulp 
stem (DPSC’s), stem cells from human exfoliated deciduous teeth (SHED), and 
stem cells from apical papilla (SCAP) cells (Figure 5).  
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Figure 5:  Overview of Dental Stem Cells. Different types of dental 
mesenchymal stem cells can be categorized by their location of origin and 
specific tissue.  Figure taken from Sharp (2016).  
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Types of nondental oral stem cells include dental follicle stem cells 
(DFSC’s), periodontal ligament stem cells (PDLSC’s) and gingival mesenchymal 
stem cells (GMSC’s) (Heng et al, 2017) (Figure 6). All of the adult stem cells are 
mesenchymal stem cells in character. Chondrocytes and osteoblasts are derived 
from a common mesenchymal stem cell (MSC), even though their process of 
differentiation is very different (Caplan, 1991). Adult MSC’s, because of their 
presence in gingival connective tissue, have osteogenic potential and thus are 
capable of bone regeneration in mandibular defects. They also have been found 
to promote bone regeneration by inhibiting lymphocyte proliferation and cytokines 
and thus restricting the inflammatory response (Shakoori et al, 2017).  
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Figure 6:  Classification of Stem Cells in Dentistry. Five various types of 
dental stem cells have been isolated including dental pulp stem cells, periodontal 
ligament stem cells, stem cells from exfoliated deciduous teeth, dental follicle 
progenitor cells, and stem cells from the apical papilla.  Figure taken from 
Khazaei et al. 2016. 
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Regulatory T-cells and anti-inflammatory cytokines are also being 
recruited by these stem cells (Bansal & Jain, 2015). Embryonic stem cells are 
only found in the blastocyst stage of development while induced pluripotent stem 
cells are considered a new source of stem cells. It has been discovered that 
induced pluripotent stem cells are derived from adult cells by introducing four 
pluripotency genes, Oct4, Sox2, cMyc, KIf4 (Shakoori et al, 2017). Table 1 
summarizes many of these results. 
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Table 1: Overview of studies describing stem cells and their roles in 
improving disease models (Shakoori et al, 2017) 
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There are non-dental stem cells that are also used for dental application. 
In a recent study by Cai et al (2016), a possible method was reported in which 
pluripotent stem cells derived from human urine were used for growing teeth in 
mice. The generated teeth in mice had physical properties similar to that of 
normal human teeth with few exceptions. The advantages to this approach 
included a noninvasive technique, and a low cost (Bansal & Jain, 2015). 
Furthermore, dental stem cells can also be used in a vast array of fields in 
medicine. A major advantage of dental stem cells is their increased availability 
through routine biological waste produced during dental treatments that would 
otherwise not be used (Heng et al, 2016). Some examples include applications 
like regenerating brain tissue, and heart therapies. A study in 2008 by de 
Mendonca et al, showed  human dental pulp stem cells were used to reconstruct 
large-sized cranial defects in rats. These studies and applications are only a 
small example of the multiple applications and potential that stem cells of dental 
origin have in the ability of reconstructing not only skeletal bone but craniofacial 
structures as well. Many of the studies are confined to animal subjects and even 
though expanding rapidly, it is important to consider that stem cells are less 
potent than embryonic stem cells.  
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Signaling in Bone Regeneration 
 Bone regeneration is possible through highly organized and coordinated 
pathways. Several signaling molecules have been found to take place in the 
different phases described above and all lead to enhance MSCs in bone fracture 
(Shakoori et al, 2017). The first growth factors found to induce osteoblast 
differentiation were BMP2 and BMP7. There are also certain therapeutic agents 
that target the Wnt signaling pathway which also service as direct osteoblast 
inducers. Factors such as platelet derived growth factor (PDGF) or fibroblast 
growth factor (FGF) have roles of mitogens and thus serve to increase the 
number of bone producing cells and therefore increase vascularization. Vascular 
endothelial growth factor (VEGF) has a special role, where it not only induces 
new blood vessel formation but it has a direct effect on BMP production.  Table 2 
indicates several signaling processes in each of the bone regeneration phases 
(Hankenson et al, 2015).  
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Table 2: Studies that demonstrate extracellular signaling molecules to 
promote bone regeneration (Hankenson et al, 2015) 
 
 
Phase of 
Healing 
Treatment Subject Outcome 
Inflammation Pro-macrophage 
cytokine factor-1 
Mouse Enhanced soft callus 
formation  
Anti-TNF alpha 
antibody 
Mouse Fracture healed  
Erythropoeitin Mouse Increased bone density 
Erythropoetin Mouse Enhanced consolidation 
of bony callus  
Cellular 
proliferation 
rhPDF-BB (PUT 
ABBV) 
Human Significant periodontal 
defect fill 
AMD3100 Mouse Larger fracture callus 
and increased bone 
material density  
bFGF Rat 
(diabetic) 
Increased number of 
osteocytes and 
improved bone repair  
Angiogenesis DFO (HIF 
Stabilization) 
Mouse Increased bone 
formation  
VEGF Mouse Increased vascularity in 
soft tissue around 
fracture area  
MSC 
Differentiation  
Beta-catenin 
(stabilization of 
Wnt signaling) 
Mouse Enhanced fracture 
consolidation 
 Anti-Dkk1 Mouse Enhanced fracture 
callus formation  
 Wnt3a Mouse Faster bone 
regeneration  
 R-spondins Mouse Promotes bone 
formation in mouse 
models of osteoporosis  
 P-15 Humans Early incorporation of 
bone graft of lumbar 
fusion 
Bone 
remodeling 
RANKL inhibitor Mouse Delayed bone 
remodeling but 
enhanced bone 
strength  
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 One should also consider the effects and consequences of producing 
MSCs for clinical applications. Precursors of MSCs have been found in blood 
vessels and most of human tissues and thus it is possible to obtain them from an 
unlimited number of organs. However, it can be challenging and could 
compromise the safety of the donor. In 2010, Lin et al concluded that for bone 
marrow (BM), the age of the donor is inversely correlated to the yield of MSCs 
obtained. The opposite has been found for adipose tissue derived MSCs and the 
age of the donor (Shi et al, 2005).  
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SPECIFIC AIMS OR OBJECTIVES 
 
      Current literature on stem cells in bone is aimed at developing therapeutic 
approaches for bone repair and bone regeneration. There are several downsides 
to bone grafting which makes this a promising alternative approach. Several 
initial studies have demonstrated that therapy with mesenchymal stem cells 
(MSC) have been helpful in regenerating bone in fracture healing. However, it is 
also important to recognize that these studies are done in animal models and the 
clinical translation to human subjects is quite challenging. This thesis will focus 
on introducing these studies, and explaining the current advances in those 
experiments, especially on oral bone regeneration/craniofacial regeneration.  
• Discuss how stem cells work  
• Discuss how bone regeneration works 
• Identify studies of stem cell in skeletal bone regeneration 
• Identify studies of stem cell in craniofacial regeneration 
• Discuss the types of benefits that stem cell use can have in improving 
human disease conditions  
 
From the objectives above, we hope to learn how stem cells are able to play a 
role in the betterment of bone regeneration.  
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PUBLISHED STUDIES 
 
 In vitro differentiation of neural-like cells from human teeth-derived stem 
cells has been studied by Nourbakhsh et al in 2011 (Figure 7) (Nakamura et al, 
2009). Obtaining SHED is a better alternative in obtaining stem cells as it causes 
no harm or injury in children who lose primary teeth. Furthermore, DPSC 
isolation is possible even five days after tooth extraction, which demonstrates the 
usefulness of obtaining stem cells from children who are losing primary teeth 
(Nourbakhsh et al, 2011). The proliferation rate of SHED cells, however, is higher 
than DPSCs and BM-MSCs (Figure 8) (Nourbakhsh et al, 2011). 
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Figure 7: SHED Cell Differentiation:   Image by phase contrast shows SHED 
cell differentiation five (A) and ten (B) days after neural induction. Figure taken 
from Nourbakhsh et al, 2011. 
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Figure 8: Network of cell proliferation. A) Pathway analysis of gene categories 
that were prominent in SHED compared with DPSCs. B-E) PCR analysis 
performed to validate the expression level of the genes in the cell proliferation 
pathway. FGF2, TGF-beta 2, Col I, and Col II had a higher expression in SHED 
compared with DPSCs.  Figure taken from Nakamura et al, 2009.  
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Kerkis et al (2008) concluded that SHED cells cause no harm by 
implanting human SHED cells to golden retriever muscular dystrophy dogs; no 
immune rejection was present and the dogs presented with betterment in their 
bone engraftment and clinical conditions. After culturing SHED cells, viable cells 
with elongated shapes were detected after one day. Additionally, these cultured 
SHED cells expressed the marker ALP while the ex vivo-expanded SHED cells 
expressed the cell surface molecules STRO-1 and CD146, which are two early 
MSC markers found in bone marrow mesenchymal stem cells. In order to 
evaluate whether SHED cells could later differentiate into mineralized cells, the 
cells were supplemented with L-ascorbate-2-phosphate, dexamethasone, and 
inorganic phosphate. The results showed calcium accumulation in vitro (Kerkis et 
al, 2008).  
Experimental evidence for bone tissue engineering was given support by a 
study performed by Quarto in 2001. This study published results obtained in 
three patients with several severe bone defects. Bone marrow stem cells were 
isolated and expanded ex vivo under the stimulation of several growth factors 
before the implantation of hydroxyapatite scaffolds for each bone defect. Through 
this implantation, all patients recovered limb function and after several months, 
good integration of the cells with the recipient was observed. After the 
implantation, the use of autologous bone marrow encased within a titanium cage 
with bone mineral blocks for reconstructive mandibular reconstruction was 
reported. This was implanted in the latissimus dorsi muscle for seven weeks to 
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allow for vascularization and growth before transplantation of the bone muscle 
flap. This treatment has been deemed successful in patients after 6-7 years of 
follow up (Quarto et al. 2001). 
Stem cells have also been used in the treatment of several blood diseases 
and other types of diseases. Parkinson’s disease is a movement disorder that is 
characterized by the damage of neurons in the midbrain, which results in 
stiffness, rest tremor, and bradykinesia. It has been shown that embryonic stem 
cells have the ability to differentiate into neural stem cells which in turn develop 
into dopaminergic neurons. A study published by Sonntag et al. (2007) showed 
that the combination of these cells with a bone morphogenic protein antagonist 
(Noggin) results in a higher production of stem cells that can differentiate into 
dopaminergic neurons. Venkataramana et al (2010) used mesenchymal cells and 
injected them into a ventricular area of seven patients with Parkinson’s disease 
and observed improvement in several symptoms, including: gait, freezing 
episodes, and facial gestures. Induced pluripotent stem cells and fetal neural 
stem cells have also been used in a study for the treatment of Parkinson disease 
patients (Figure 9) (Venkataramana et al, 2010).   
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Figure 9: Imaging before and after stem cell transplantation. There was no 
abnormal evidence after stem cell transplantation nor were there any other 
significant changes in these images. Figure taken from Venkataramana et al, 
2010. 
 
 
 
 
However, the use of iPSCs have led to tumor in those patients (Wernig et 
al, 2008). Stem cells have also been used in the improvement of patients with 
amyotrophic lateral sclerosis (ALS), amyotrophic lateral sclerosis. It is a fatal 
neurodegenerative disease that is characterized with the destruction of neurons 
of the spinal cords and neurons of the brain. Xu et al in 2009 showed the 
replacement of human neural stem cells in mice resulted in their differentiation to 
neurons with GABA (gamma-aminobutyric acid) ergic phenotype which led to 
28 
 
beneficial effects for motor neurons and thus improved the symptoms. It has also 
been shown that astrocyte replacement through injected astrocytes called Glial-
Restricted precursors increased survival in mice, slowed down respiratory 
disorders, and reduced motor neuron damage (Lepore et al, 2008). 
Mesenchymal stem cells were used in muscles of mice with familial ALS; these 
cells caused glial cell factor secretion which served to increase the number of 
motor neuron cell bodies in the spinal cord and prolonged survival for 28 days 
(Suzuki et al, 2008). Alzheimer’s disease is also a neurodegenerative disease 
which has shown improvement with the use of stem cells. Neural stem cells have 
been used because they have the ability to differentiate into neurons, astrocytes, 
and oligodendrocytes. Neural stem cells were injected into the basal part of the 
forebrain of rats and it was observed that the group which received the injection 
had a much greater number of cholinergic neurons versus the group that had not 
received any treatment  (Table 3)(Xuan et al, 2009).  
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Table 3 : BNDF and NSCs increase the number of cholinergic neurons. 
Comparison of medial septum and vertical diagonal band of brain in rats. Table 
taken from Xuan et al, 2009. 
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 Embryonic and neural stem cells have also been shown to play a huge 
role in the treatment of spinal cord injury. The injection of embryonic stem cells, 
as demonstrated in a study by Kerr et al in 2010, increased neurological 
responses in treated mice compared with control mice. However, it was also 
found these cells can cause tumors and thus making it challenging to develop a 
study similar to that for humans.  Olfactory ensheathing cells are special glial 
cells that only exist in the olfactory system and aid with the production of 
olfactory neurons. Lopez-Vales et al, in 2006, examined the use of these cells in 
rats and found that the injection of olfactory ensheathing cells improved 
performance and behavior with an increased regeneration of axons. In stroke, 
many studies have shown to facilitate the improvement of symptoms and have 
been shown to help in the protection of neurons, regulation of immune system, 
the increase of internal healing processes, and vascular regeneration. A study 
led by Gupta et al in 2007 demonstrated that autologous stem cells injected in 
children resulted in an improvement in their deteriorating condition. From an 
initial 12 children, 5 patients died due to cirrhosis, 4 patients recovered from 
cholangitis, and in 9 patients either liver stiffness of liver function was improved. 
Table 4 summarizes the different types of stem cells that have been in used in 
the treatment for stroke (Larijani et al, 2012, Gupta et al, 2007).  
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Table 4: Different types of stem cells used in the treatment of stroke. 
Different types of cells used for the protection of neurons, regulation of immune 
system, increase of internal healing processes, and vascular regeneration are 
shown. (Larijani et al, 2012) 
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 Stem cells have also been shown to help with bone diseases, where 
mesenchymal cells will differentiate to chondrocytes and osteoblasts and lead to 
a fracture heal. Non ununion is an orthopedic issue which causes very prolonged 
hospitalization. In a study by Marcacci et al, 2007, bone marrow stromal cells 
were grafted in defective areas in four patients with large bone disorders. After 
some time, radiography and CT scans showed that bone healing had occurred. 
The same effect can be observed in osteogenesis imperfecta, a hereditary 
disorder that is characterized by bone fragility, bone density reduction, and 
connective tissue disorders. Mesenchymal cells were examined in humans in a 
study by Horwitz et al in 2002. Mesenchymal cells derived from bone marrow of 
donors were injected twice into six children with severe osteogenesis imperfecta 
(OI) who had been treated with normal bone marrow transplantation previously. 
These patients, in comparies to those patients that were the same age and sex 
but had not received treatment, improved an average of 70 percent with no side 
effect (Figure 10) (Horwitz et al, 2002).   
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Figure 10: Growth Stimulation in Osteoimperfecta Patients. Growth velocity 
of the paitnets during the 6 months immediate before (light shadow) and after 
(dark shadow) the first MSC infusion. Figure taken from Horwitz et al, 2002.  
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Hypophosphatasia is a rare disorder which results in metabolic bone 
disorder because of reduction of tissue-nonspecific alkaline phosphatase activity. 
This disease in children comes in the form of rickets which leads to death in the 
first years of life because of weakness in respiratory muscles. No treatment by 
any drug has been found, however, Cahill et al in 2007, injected heterogeneous 
stem cells into three different locations intraperitonealy, subcutaneously, and 
intravenously. Four months after the injection, evidence showed increased 
mineralization and after seven years, the child was active and had demonstrated 
a reduced severity of the disease (Figure 10) (Cahill et al in 2007).   
 
  
35 
 
 
 
 
 
 
 
 
Figure 11: Knee radiographs before and after bone transplantation.  
Radiographs of the right knee comparison of before (Figures A-C) and after (D-
G) bo ne transplantation. Significant imporvement is shown in the reappearance 
of the epiphyses after treatment. Figure taken from Cahill et al in 2007. 
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 The regeneration of ischemic cardiac muscle and vascular endothelium 
was studied by Jackson et al in 2001. To identify a source of stem cells capable 
of restoring damaged cardiac tissue, the group transplanted hematopoietic stem 
cells into irradiated mice by coronary artery occlusion for 60 minutes. The 
engrafted cells migrated into ischemic cardiac muscle and blood vessels, 
differentiated to cardiomyocytes and endothelial cells and finally contributed to 
the formation of functional tissue. When transpalanted into the bone marrow of 
irradiated mice, these cells marked with the lacZ gene regenerated the 
hematopoietic system. It was also found that lacZ positive cells could also 
participate in neovascularization in regenerating heart tissue. The results of this 
study demonstrate the potential of hemopoietic stem cells in a strategy that could 
eventually be used in human patients (Jackson et al in 2001).   
 Several studies have also focused on stem cell therapy in craniofacial 
bone regeneration. A randomized controlled trial conducted by Kaigler et al in 
2013 investigated tissue repair cell therapy through stem cells to reconstruct 
defects in craniofacial bone. The study involved twenty four patients who were 
randomized to receive either guided bone regeneration (GBR) or tissue repair 
cell transplantation. Bone biopsies were obtained and the patients under went 
quantitative micro-computer tomographic and bone histomorphometric analysis. 
Oral implants were placed in the patients, restored, and loaded with tooth 
restorations; the patients were followed up for the treatment for 1 year following 
therapy. Following a 6 week period, it was shown there was greater radiographic 
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bone height in patients that received the tissue repair cell transplantation versus 
the group that received guided bone regeneration. At 12 weeks, the tissue repair 
cell group showed 80.1 bone fill while the guided bone regeneration group 
showed 74.6 bone fill. Figure 2 shows images of tissue repair cell and guided 
bone regeneration treatment sites at time 0, 6 weeks following treatment, and 
fully restored 1 year after the initial surgery. The study determined that in the 
guided bone regenration group, the regenerated tissues at 6 weeks appeared 
fibrous and vascular, with many specimens being notably soft during biopsy. 
However, the tissues in the tissue repair cell group exhibited a bone like 
appearance clinically, achieved higher vascularity, and were more dense. 
Additionally, the study found there was a greater need for the guided bone 
regeneration group to receive secondary bone grafting procedures, compared to 
the tissue replacement cell transplantation group. In the GBR groups at 6 and 12 
weeks there was sixfold greater implant exposure which needed more extensive 
secondary grafting, relative to the need in the tissue repair cell treated group. 
The sizes of the implants used in both groups were very similar and all implants 
achieved integration into the bone following 6 months after treatment. Bone core 
biopsies were also analyzed at 6 and 12 weeks; bone volume fraction and bone 
mineral density were measured. At 6 weeks, the bone volume fraction for the 
guided bone regeneration group was 13, compared to 28 for the tissue repair cell 
transplantation group. Bone repair in the tissue repair cell group had a greater 
than twofold bone mineral density, as well. However, upon the analysis at 6 and 
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12 weeks, no statistically significant differences were found in measures of 
percent bone area/tissue area (Kaigler et al, 2013).  
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Figure 12: Comparing results for guided bone regeneration and tissue 
repair cell groups in implants A) Radiographic images of bone height density 
for guided bone regeneration groups and tissue repair cell groups B) 
Standardized digital radiography used to analyze linear changes in bone height 
C) Clinical photographs of the treatment site following removal of the tooth, at 
reentry after 6 weeks, and 12 months after treatment with full restoration with a 
crown D) Residual bone defects were noticed in some patients E) Tomographic 
and histomorphometric analyses used for bone volume fraction and bone mineral 
density. Figure taken from Kaigler et al in 2013. 
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DISCUSSION 
 
 
 Many studies are evaluating the use tissue engineering as regenerative 
medicine. In the studies described above and many other studies, the 
mechanism of intrinsic bone repair has been very effectitive with very little 
external intervention required. Bone tissue engineering has demonstrated to 
bring clinical relief and is especially important because it allows application to a 
greater number of patients, especially to those patients for whom traditional bone 
grafting procedures are unfeasible. The changing trend to acquire a 
developmental engineering approach in the reformation of bone follow closely the 
natural process of bone development as outlined in the introduction of this thesis, 
through the remodeling of hypertrophic cartilage templates via endochondral 
ossification (Fisher et al, 2016).  
 Even though the mentioned studies provide layers of evidence and help 
catalyze future studies in stem cells and bone regeneration, it is important to 
acknowledge that much is still left to be accomplished in this field. Both decidious 
teeth and permanent teeth are able to differentiate into osteoblasts, adipocytes, 
and chrondrocytes, although quantification results indicated that decidious teeth 
exhibited better differentiation quality than permament teeth. It was found that 
decidious teeth are capable of differentiating both in vitro and in vivo into 
osteoblasts, adiposytes, odontoblasts, and even hepatocytes. Permanent teeth, 
however, were more appropriate for dental tissue regeneration and 
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neurodegenerative diseases (Govindasamy et al, 2010). This is important to 
acknowledge when choosing the most desirable cells for a specific outcome in 
bone regeneration. Not only knowing which cells differentiate most appropriately 
but also knowing which stem cells are most appropriate to use are key factors in 
bone tissue engineering.  
 Govindasamy et al, in 2010, also demonstrated dental pulp stem cells 
were likely to have the greatest potential for neural differentiation than any other 
stem cells. One possible test to evaluate the differentiation quality of varying cells 
is to test the presence of neuroal mRNA and determine whether that affects end 
point differentiation. This was done with decidious and permanent teeth through 
the induction of neurospheres in which cells aggregate to floating spheres 
(Reynolds et al, 1992). An interesting finding was that neurospheres were found 
in a higher amount in permanent teeth compared to decidious teeth. One of the 
most probable reasons for that finding is the fold expression of nestin that was 
found in permanent teeth versus decidious teeth (Dahlstrand et al, 1995).  Nestin 
is an essential part in the formation of neurospheres, and the abundant 
expression of nestin in permanent teeth could enable permanent teeth cells to 
differentiate more efficiently than decidious teeth. There is not enough proof of 
that and it is something that would be a step forward in evaluating the use of 
dental stem cells in bone regeneration and reformation. Figure 12 gives a quick 
summary of how dentistry could be transformed in the next 10 years with these 
new possible methods as described above.  
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Figure 13: Future of Dentistry. Figure showing the future of dental research in 
the next 10 years and how stem cells could be used to correct many oral issues, 
including bone reformation (Figure taken from Elevate Strategy Consulting , n.d. 
http://elevatestrategyconsulting.com/innovation/stemcellsindentistry/) 
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 Several recent advances in biomaterails have led to a transition from non-
porous, inert materials to more osteoconductive, more porous biomaterials. 
These can be used as delivery machines, such as porous ceramics of 
hydroxyapatite and beta-tricalcium phosphate loaded with MSC’s (Mao et al, 
2006). Mesenchymal stem cells can be obtained from the same individual and 
induced to differentiate into both osteogenic and chondrogenic cells (Nakayama 
et al, 2003).  
There are many challenges ahead that limit the development and 
availability of these therapeutic treatment approaches. Additionally, between 
countries, the unequal resources, differences in access to opportunities by the 
local population, and variable standards of public and community health 
comprise another major hurdle to overcome to achieve success in this field.  
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